SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-19-000020
Filing Date
2019-05-01
Accepted
2019-05-01 16:11:19
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flks2019033110-q.htm 10-Q 645763
2 EXHIBIT 31.1 flks20190331ex-311.htm EX-31.1 10242
3 EXHIBIT 31.2 flks20190331ex-312.htm EX-31.2 10291
4 EXHIBIT 32.1 flks20190331ex-321.htm EX-32.1 9391
  Complete submission text file 0001615219-19-000020.txt   3533348

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flks-20190331.xml EX-101.INS 606265
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20190331.xsd EX-101.SCH 29730
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20190331_cal.xml EX-101.CAL 47260
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20190331_def.xml EX-101.DEF 129391
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20190331_lab.xml EX-101.LAB 424612
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20190331_pre.xml EX-101.PRE 251300
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 19787591
SIC: 2834 Pharmaceutical Preparations